APA (7th ed.) Citation

N, M., X, L., Y, S., Z, O., A, A., Y, E., . . . WJ, W. (2021). A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action. Cancers, 13(5), . https://doi.org/10.3390/cancers13051027

Chicago Style (17th ed.) Citation

N, Mohan, Luo X, Shen Y, Olson Z, Agrawal A, Endo Y, Rotstein DS, Pelosof LC, and Wu WJ. "A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective Against Triple Negative Breast Cancer via Multiple Mechanisms of Action." Cancers 13, no. 5 (2021). https://doi.org/10.3390/cancers13051027.

MLA (9th ed.) Citation

N, Mohan, et al. "A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective Against Triple Negative Breast Cancer via Multiple Mechanisms of Action." Cancers, vol. 13, no. 5, 2021, https://doi.org/10.3390/cancers13051027.